Exchange: NYSE·Updated 07:59 PM EST

JNJ News

News
all
press releases
Best Healthcare Stocks To Watch Today - November 21st
Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, AbbVie, Amgen, Merck & Co., Inc., and Moderna are the seven Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies that provide healthcare products or se...
MarketBeat
Best Healthcare Stocks To Watch Today - November 21st
Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, AbbVie, Amgen, Merck & Co., Inc., and Moderna are the seven Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies that provide healthcare products or se...
MarketBeat
More News
Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck & Co., Inc., Gilead Sciences, Pfizer, and McKesson are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of companies that develop, manufacture, or sell medicines an...
MarketBeat
State Street Corp boosted its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 0.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 133,971,339 shares of the company's stock after purchas...
MarketBeat
UnitedHealth Group, Eli Lilly and Company, and Johnson & Johnson are the three Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies that provide healthcare-related products or services, such as pharmaceutical and...
MarketBeat
Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc., AbbVie, Insmed, Pfizer, and Gilead Sciences are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares in companies that develop, manufacture, or market prescription...
MarketBeat
JPMorgan Chase & Co. raised their target price on shares of Johnson & Johnson from $285.00 to $300.00 and gave the stock a "neutral" rating in a report on Friday...
MarketBeat
Halozyme faces a legal setback in Germany as a court overturns an injunction against Merck's Keytruda SC, prompting a new patent lawsuit.
Zacks
Johnson & Johnson data in psoriatic arthritis (PsA) shows TREMFYA (guselkumab) is the only advanced therapy to demonstrate MRI-confirmed improvements in spinal pain and stiffness Johnson & Johnson data in psoriatic arthritis (PsA) shows TREMFYA (guselkumab) is the only advanced therapy to...
PR Newswire
Johnson & Johnson (NYSE:JNJ) Stock Price Breaks Below 50-Day Moving Average - What's Next...
MarketBeat
Advisors Asset Management Inc. purchased a new stake in Johnson & Johnson (NYSE:JNJ - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 211,779 shares of the company's stock, valued at approxim...
MarketBeat

Advertisement|Remove ads.